We are live on ! Find out more
NSEDCP

NJ State Employees Deferred Compensation Plan Portfolio holdings

AUM $906M
1-Year Est. Return 24.85%
This Fund
S&P 500
This Quarter Est. Return
+3.65%
1 Year Est. Return
+24.85%
3 Year Est. Return
+127.22%
5 Year Est. Return
+201.43%
10 Year Est. Return
+564.84%
AUM
$560M
AUM Growth
-$1.32M
Cap. Flow
-$13.2M
Cap. Flow %
-2.35%
Top 10 Hldgs %
18.32%
Holding
543
New
74
Increased
58
Reduced
117
Closed
43

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$3.79M
2
TWX
Time Warner Inc
TWX
+$3.47M
3
MON
Monsanto Co
MON
+$2.33M
4
AAPL icon
Apple
AAPL
+$1.81M
5
GILD icon
Gilead Sciences
GILD
+$1.27M

Sector Composition

Rank Sector Weight
1 Technology 19.2%
2 Financials 17.49%
3 Industrials 13.77%
4 Healthcare 10.47%
5 Consumer Discretionary 8.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OII icon
401
Oceaneering
OII
$4.86B
$356K 0.06%
14,000
-30,000
-68% -$672K
LOGM
402
DELISTED
LogMein, Inc.
LOGM
$355K 0.06%
3,436
ACH
403
Accendra Health
ACH
$237M
$351K 0.06%
21,000
VSH icon
404
Vishay Intertechnology
VSH
$5.25B
$350K 0.06%
15,087
-20,000
-57% -$417K
AVP
405
DELISTED
Avon Products, Inc.
AVP
$348K 0.06%
215,000
+40,000
+23% +$84.7K
AUBN icon
406
Auburn National Bancorp
AUBN
$91.3M
$347K 0.06%
+7,000
New +$306K
EMR icon
407
Emerson Electric
EMR
$83.9B
$346K 0.06%
5,000
ALTR
408
DELISTED
Altair Engineering Inc
ALTR
$342K 0.06%
+10,000
New +$327K
BW icon
409
Babcock & Wilcox
BW
$1.39B
$341K 0.06%
+14,325
New +$381K
XLRN
410
DELISTED
Acceleron Pharma
XLRN
$340K 0.06%
7,000
TR icon
411
Tootsie Roll Industries
TR
$2.93B
$339K 0.06%
13,934
-2,534
-15% -$58.5K
CACI icon
412
CACI
CACI
$11B
$337K 0.06%
+2,000
New +$323K
MUSA icon
413
Murphy USA
MUSA
$11.2B
$334K 0.06%
4,500
ROG icon
414
Rogers Corp
ROG
$2.21B
$334K 0.06%
3,000
SFBS
415
ServisFirst Bancshares
SFBS
$4.89B
$334K 0.06%
8,000
BPRN icon
416
Princeton Bancorp
BPRN
$281M
$333K 0.06%
+10,000
New +$334K
RDN icon
417
Radian Group
RDN
$5.18B
$324K 0.06%
20,000
KSU
418
DELISTED
Kansas City Southern
KSU
$318K 0.06%
3,000
CHK
419
DELISTED
Chesapeake Energy Corporation
CHK
$314K 0.06%
300
-300
-50% -$232K
NTGR icon
420
NETGEAR
NTGR
$648M
$313K 0.06%
5,000
LM
421
DELISTED
Legg Mason, Inc.
LM
$313K 0.06%
9,000
RIGL icon
422
Rigel Pharmaceuticals
RIGL
$681M
$311K 0.06%
11,000
-4,000
-27% -$142K
KMI icon
423
Kinder Morgan
KMI
$71.7B
$305K 0.05%
17,265
WPX
424
DELISTED
WPX Energy, Inc.
WPX
$300K 0.05%
16,666
BZH icon
425
Beazer Homes USA
BZH
$877M
$295K 0.05%
+20,000
New +$307K

Similar funds

NJ State Employees Deferred Compensation Plan's Q2 2018 Portfolio in Review

As of Q2 2018, NJ State Employees Deferred Compensation Plan held 543 positions worth $560M, down 0.24% from $561M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

NJ State Employees Deferred Compensation Plan's Q2 2018 filing shows 74 new, 58 increased, 117 reduced and 43 closed positions. Its largest new stake was Wyndham Hotels & Resorts: 17,859 shares worth $1.05M. The largest sale was AbbVie, an estimated $3.79M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Financials and Industrials.

  • NJ State Employees Deferred Compensation Plan's largest Q2 2018 buy was Wyndham Hotels & Resorts: 17,859 shares worth $1.05M.
  • NJ State Employees Deferred Compensation Plan added most to Meta Platforms (Facebook) in Q2 2018, an estimated $3.61M increase.
  • NJ State Employees Deferred Compensation Plan's biggest Q2 2018 reduction was Apple, cutting an estimated $1.81M.
  • NJ State Employees Deferred Compensation Plan fully exited AbbVie in Q2 2018, selling an estimated $3.79M.
  • NJ State Employees Deferred Compensation Plan's ten largest holdings make up 18% of its $560M portfolio in Q2 2018.
  • NJ State Employees Deferred Compensation Plan opened 74 new positions and closed 43 in Q2 2018.
  • NJ State Employees Deferred Compensation Plan's portfolio value fell 0.24% quarter-over-quarter to $560M.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q2 2018, filed 2 Aug 2018.